5 Future directions
5.1.7 Effect of recombinant activated factor VII on outcomes
Question 7 (interventional)
In patients undergoing surgery, what is the effect of rFVIIa (prophylaxis or treatment) on morbidity, mortality and transfusion rate?
rFVIIa, recombinant activated factor VII
Well-designed studies are needed to determine the impact of prophylactic or therapeutic use of rFVIIa on morbidity and mortality (including thrombosis) in surgical patients.